Ginger D. Constantine

4.8k total citations
97 papers, 3.5k citations indexed

About

Ginger D. Constantine is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ginger D. Constantine has authored 97 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Endocrinology, Diabetes and Metabolism, 51 papers in Genetics and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ginger D. Constantine's work include Menopause: Health Impacts and Treatments (54 papers), Estrogen and related hormone effects (51 papers) and Bone health and osteoporosis research (15 papers). Ginger D. Constantine is often cited by papers focused on Menopause: Health Impacts and Treatments (54 papers), Estrogen and related hormone effects (51 papers) and Bone health and osteoporosis research (15 papers). Ginger D. Constantine collaborates with scholars based in United States, Canada and Denmark. Ginger D. Constantine's co-authors include James H. Pickar, David F. Archer, JoAnn V. Pinkerton, Arkadi Chines, Sebastián Mirkin, Shelli Graham, Brian Bernick, Claus Christiansen, Margery Gass and Risa Kagan and has published in prestigious journals such as Circulation, American Journal of Obstetrics and Gynecology and Journal of Bone and Mineral Research.

In The Last Decade

Ginger D. Constantine

95 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ginger D. Constantine United States	31	1.8k	1.7k	832	751	748	97	3.5k
James H. Pickar United States	33	2.8k 1.6×	2.7k 1.6×	455 0.5×	610 0.8×	1.1k 1.5×	91	3.9k
T. J. de Villiers South Africa	19	761 0.4×	910 0.5×	322 0.4×	369 0.5×	401 0.5×	38	1.7k
Veronica A. Ravnikar United States	18	929 0.5×	1.2k 0.7×	191 0.2×	276 0.4×	415 0.6×	31	2.3k
Yu Z. Bagger Denmark	28	697 0.4×	621 0.4×	1.4k 1.6×	751 1.0×	361 0.5×	45	3.1k
Marius J. van der Mooren Netherlands	32	1.2k 0.7×	1.6k 0.9×	108 0.1×	408 0.5×	386 0.5×	109	2.8k
Elizabeth Barrett-Connor United States	8	716 0.4×	1.1k 0.7×	584 0.7×	293 0.4×	319 0.4×	8	2.3k
Cynthia A. Stuenkel United States	26	996 0.6×	1.4k 0.8×	70 0.1×	297 0.4×	473 0.6×	68	2.6k
I. M. Holdaway New Zealand	24	592 0.3×	1.6k 0.9×	229 0.3×	566 0.8×	894 1.2×	98	3.8k
Peter Eggena United States	30	703 0.4×	1.4k 0.8×	128 0.2×	146 0.2×	252 0.3×	116	3.1k
Léonello Cusan Canada	30	859 0.5×	1.7k 1.0×	52 0.1×	286 0.4×	239 0.3×	42	3.2k

Countries citing papers authored by Ginger D. Constantine

Since Specialization

Citations

This map shows the geographic impact of Ginger D. Constantine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginger D. Constantine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginger D. Constantine more than expected).

Fields of papers citing papers by Ginger D. Constantine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginger D. Constantine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginger D. Constantine. The network helps show where Ginger D. Constantine may publish in the future.

Co-authorship network of co-authors of Ginger D. Constantine

This figure shows the co-authorship network connecting the top 25 collaborators of Ginger D. Constantine. A scholar is included among the top collaborators of Ginger D. Constantine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginger D. Constantine. Ginger D. Constantine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simon, James A., Risa Kagan, David F. Archer, et al.. (2019). TX-004HR clinically improves symptoms of vulvar and vaginal atrophy in postmenopausal women. Climacteric. 22(4). 412–418. 8 indexed citations

Constantine, Ginger D., et al.. (2018). Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors. Journal of Women s Health. 28(2). 237–243. 106 indexed citations

Løbo, Rogerio A., David F. Archer, Risa Kagan, et al.. (2018). A 17β-Estradiol–Progesterone Oral Capsule for Vasomotor Symptoms in Postmenopausal Women: A Randomized Controlled Trial. Obstetrical & Gynecological Survey. 73(11). 630–632. 2 indexed citations

Constantine, Ginger D., Céline Bouchard, James H. Pickar, et al.. (2017). Consistency of Effect with a Low-Dose, Estradiol Vaginal Capsule (TX-004HR): Evaluating Improvement in Vaginal Physiology and Moderate-to-Severe Dyspareunia in Subgroups of Postmenopausal Women. Journal of Women s Health. 26(6). 616–623. 12 indexed citations

Kingsberg, Sheryl A., Robin Kroll, Irwin Goldstein, et al.. (2017). Patient acceptability and satisfaction with a low-dose solubilized vaginal estradiol softgel capsule, TX-004HR. Menopause The Journal of The North American Menopause Society. 24(8). 894–899. 11 indexed citations

Constantine, Ginger D., et al.. (2016). Behaviours and attitudes influencing treatment decisions for menopausal symptoms in five European countries. Post Reproductive Health. 22(3). 112–122. 52 indexed citations

Bouchard, P, et al.. (2011). Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms. Climacteric. 15(1). 12–20. 32 indexed citations

Halbreich, Uriel, Ellen W. Freeman, Andrea J. Rapkin, et al.. (2011). Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder. Contraception. 85(1). 19–27. 35 indexed citations

Freeman, Ellen W., Uriel Halbreich, Gary S. Grubb, et al.. (2011). An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome. Contraception. 85(5). 437–445. 64 indexed citations

10.

Christiansen, Claus, Charles H. Chesnut, Jonathan D. Adachi, et al.. (2010). Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis. BMC Musculoskeletal Disorders. 11(1). 130–130. 71 indexed citations

11.

Pinkerton, JoAnn V., David F. Archer, Wulf H. Utian, et al.. (2009). Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis. Menopause The Journal of The North American Menopause Society. 16(6). 1102–1108. 65 indexed citations

12.

Teíchmann, A., Dan Apter, Janusz Emerich, et al.. (2009). Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial. Contraception. 80(6). 504–511. 36 indexed citations

13.

Pinkerton, JoAnn V., Wulf H. Utian, David F. Archer, et al.. (2007). Endometrial and ovarian safety of bazedoxifene (BZA) in the prevention of postmenopausal osteoporosis. Fertility and Sterility. 88. S241–S242. 3 indexed citations

14.

Johnson, Julia V., Gary S. Grubb, & Ginger D. Constantine. (2006). Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 μg/ethinyl estradiol 20 μg. Contraception. 75(1). 23–26. 26 indexed citations

15.

Teíchmann, A., et al.. (2006). Comparative Trial of Continuous-Use and 21-Day Cyclic Levonorgestrel and Ethinyl Estradiol Oral Contraceptive. Obstetrics and Gynecology. 107(Supplement). 12S–12S. 13 indexed citations

16.

Archer, David F., et al.. (2006). Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception. 74(6). 439–445. 104 indexed citations

17.

Grubb, Gary S., D. Spielmann, James H. Pickar, & Ginger D. Constantine. (2003). Clinical experience with trimegestone as a new progestin in HRT. Steroids. 68(10-13). 921–926. 10 indexed citations

18.

Constantine, Ginger D. & James H. Pickar. (2003). Estrogens in postmenopausal women: recent insights. Current Opinion in Pharmacology. 3(6). 626–634. 25 indexed citations

19.

Davidoff, Ravin, Anne McTiernan, Ginger D. Constantine, et al.. (2001). Echocardiographic Examination of Women Previously Treated With Fenfluramine. Archives of Internal Medicine. 161(11). 1429–1429. 27 indexed citations

20.

Schnitzer, Thomas J., et al.. (1995). Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with active osteoarthritis of the knee. Clinical Therapeutics. 17(4). 602–612. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact